MASLD 和 MASH 全病程中健康相关生活质量和 EQ-5D 效用——系统评价与探索性荟萃分析
Health-related quality of life and EQ-5D utility across the MASLD and MASH spectrum - a systematic review and exploratory meta-analysis
一项针对 MASLD/MASH 的系统评价与探索性荟萃分析纳入 12,265 名参与者,汇总 EQ-5D 效用数据的宏观合并估计值为 0.836(95% CI 0.781–0.890),纤维化分期提供了最明确的临床信号。合并效用值 F0–F2 期为 0.775,F3–F4 期为 0.582;研究指出效用值具有情境依赖性,而非通用可转移。
- Article
- Open access
- Published: 22 October 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Health utility estimates are required for health technology assessment and economic evaluation in metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), yet EuroQol 5-Dimension (EQ-5D) values vary across disease stages, populations, instrument versions, and national value sets. We aimed to characterise this evidence and explore sources of variation. Methods PubMed, Scopus, Embase, and CENTRAL were searched from inception to 16 February 2026. Adult studies reporting directly measured EQ-5D utility and/or EQ-VAS obtained through EQ-5D administration in MASLD/MASH or compatible historical non-alcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) populations were included. Structured qualitative synthesis was primary. Exploratory REML random-effects meta-analysis, prediction intervals, subgroup and sensitivity analyses, domain-level proportion analysis, meta-regression, and small-study-effect assessment were secondary. Certainty was appraised using a GRADE-informed framework adapted to descriptive utility evidence. Results Fourteen studies contributed EQ-5D utility data for 12,265 participants and six contributed EQ-VAS data for 3,520. The macro-level pooled EQ-5D estimate was 0.836 (95% CI 0.781–0.890; I²=99.6%). Fibrosis severity provided the clearest clinical signal: pooled utility was 0.775 (95% CI 0.732–0.817) for F0–F2 and 0.582 (95% CI 0.367–0.797) for F3–F4. The conventional advanced-minus-early difference was − 0.186 (95% CI − 0.359 to − 0.012), while Hartung-Knapp sensitivity widened the interval to − 0.570 to 0.199. Anxiety/depression (35.5%) and pain/discomfort (32.8%) were most frequently affected. Certainty in pooled magnitudes was very low. Conclusions Health utility in MASLD/MASH is context-dependent rather than universally transferable. Fibrosis stage, EQ-5D version, tariff, and population context should guide utility selection. Locally valued, stage-matched EQ-5D evidence should be prioritised, while the overall pooled estimate is best used as a benchmark or sensitivity input.
Acknowledgements
The authors gratefully acknowledge the financial support by SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRMIST, Kattankulathur for bearing the defrayed cost of publishing this article.
Funding
Open access funding provided by SRM Institute of Science and Technology for SRMIST – Medical & Health Sciences. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Author notes
These authors contributed equally to this work: G. Akshaya Kamalashree, Veeramreddy Kavya and Hariharan Murugadoss.
Authors and Affiliations
Department of General Medicine, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India
G. Akshaya Kamalashree, Veeramreddy Kavya & Aneesh Basheer
Department of Pharmacy Practice, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, India
Hariharan Murugadoss
Authors
- G. Akshaya Kamalashree
- Veeramreddy Kavya
- Hariharan Murugadoss
- Aneesh Basheer
Corresponding author
Correspondence to Aneesh Basheer.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
Ethical approval is not required as this study uses previously published data.
AI use statement
The authors acknowledge the use of AI tools solely for language editing and improving manuscript clarity. No generative artificial intelligence tools were used in the conceptualization, analysis, or drafting of scientific content.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Kamalashree, G.A., Kavya, V., Murugadoss, H. et al. Health-related quality of life and EQ-5D utility across the MASLD and MASH spectrum - a systematic review and exploratory meta-analysis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-77045-z
Received: 24 February 2026
Accepted: 16 October 2026
Published: 22 October 2026
DOI: https://doi.org/10.1038/s41598-026-77045-z
Keywords
来源:Nature 健康护理主题 · nature.com